LEXARIA BIOSCIENCE CORP. Amortization of Intangible Assets
LEXARIA BIOSCIENCE CORP. (LEXX) reported Amortization of Intangible Assets of $15.25 thousand for the 9-month period ending 2026-05-31, per its 10-Q filed 2026-07-13.
Financial Statements › Expense Statement › Operating Expenses
us-gaap:AmortizationOfIntangibleAssets · last filed 2026-07-13
- LEXARIA BIOSCIENCE CORP. amortization of intangible assets for the quarter ending 2026-05-31 was $5.29K.
- LEXARIA BIOSCIENCE CORP. amortization of intangible assets for the quarter ending 2026-02-28 was $5.10K.
- LEXARIA BIOSCIENCE CORP. amortization of intangible assets for the quarter ending 2025-11-30 was $4.86K.
- LEXARIA BIOSCIENCE CORP. amortization of intangible assets for the quarter ending 2025-08-31 was $9.39K.
- LEXARIA BIOSCIENCE CORP. amortization of intangible assets for fiscal 2025 was $36.60K.
- LEXARIA BIOSCIENCE CORP. amortization of intangible assets for fiscal 2021 was $6.87K, a 1.45% increase from fiscal 2020.
- LEXARIA BIOSCIENCE CORP. amortization of intangible assets for fiscal 2020 was $6.77K, a 54.15% increase from fiscal 2019.
- LEXARIA BIOSCIENCE CORP. amortization of intangible assets for fiscal 2019 was $4.39K, a 160.25% increase from fiscal 2018.
| Period end | Amortization of Intangible Assets 3 month | Amortization of Intangible Assets 3 month as first filed | Amortization of Intangible Assets 6 month | Amortization of Intangible Assets 9 month | Amortization of Intangible Assets 9 month as first filed | Amortization of Intangible Assets 12 month |
|---|---|---|---|---|---|---|
| 2026-05-31 | $5.29K derived: 10-Q 9 month − 10-Q 6 month · filed 2026-07-13 | $10.39K derived: sum of 2 quarters · filed 2026-07-13 | $15.25K 10-Q · filed 2026-07-13 | $24.64K derived: sum of 4 quarters · filed 2026-07-13 | ||
| 2026-02-28 | $5.10K derived: 10-Q 6 month − 10-Q 3 month · filed 2026-04-13 | $9.95K 10-Q · filed 2026-04-13 | $19.34K derived: sum of 3 quarters · filed 2026-04-13 | |||
| 2025-11-30 | $4.86K 10-Q · filed 2026-01-13 | $14.24K derived: sum of 2 quarters · filed 2026-01-13 | ||||
| 2025-08-31 | $9.39K derived: 10-K 12 month − 10-Q 9 month · filed 2025-11-28 | $36.60K 10-K · filed 2025-11-28 | ||||
| 2025-05-31 | $27.21K 10-Q · filed 2025-07-14 | |||||
| 2021-08-31 | $1.72K derived: 10-K 12 month − 10-Q 9 month · filed 2021-11-29 | $5.15K derived: sum of 2 quarters · filed 2021-11-29 | $5.15K derived: sum of 3 quarters · filed 2021-11-29 | $6.87K 10-K · filed 2021-11-29 | ||
| 2021-05-31 | $3.44K derived: 10-Q 9 month − 10-Q 6 month · filed 2021-07-15 | $3.44K derived: sum of 2 quarters · filed 2021-07-15 | $5.15K 10-Q · filed 2021-07-15 | $7.66K derived: sum of 4 quarters · filed 2021-11-29 | ||
| 2021-02-28 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2021-04-14 | $1.72K 10-Q · filed 2021-04-14 | $4.22K derived: sum of 3 quarters · filed 2021-11-29 | $5.65K derived: sum of 4 quarters · filed 2021-11-29 | ||
| 2020-11-30 | $1.72K 10-Q · filed 2021-01-14 | $4.22K derived: sum of 2 quarters · filed 2021-11-29 | $5.65K derived: sum of 3 quarters · filed 2021-11-29 | $7.07K derived: sum of 4 quarters · filed 2021-11-29 | ||
| 2020-08-31 | $2.51K derived: 10-K 12 month − 10-Q 9 month · filed 2021-11-29 | $3.93K derived: sum of 2 quarters · filed 2021-11-29 | $5.35K derived: sum of 3 quarters · filed 2021-11-29 | $6.77K 10-K · filed 2021-11-29 | ||
| 2020-05-31 | $1.42K derived: 10-Q 9 month − 10-Q 6 month · filed 2020-06-29 | $2.84K derived: sum of 2 quarters · filed 2020-06-29 | $4.26K 10-Q · filed 2020-06-29 | $5.45K derived: sum of 4 quarters · filed 2020-10-15 | ||
| 2020-02-29 | $1.42K derived: 10-Q 6 month − 10-Q 3 month · filed 2020-04-03 | $2.84K 10-Q · filed 2020-04-03 | $4.03K derived: sum of 3 quarters · filed 2020-10-15 | $5.14K derived: sum of 4 quarters · filed 2020-10-15 | ||
| 2019-11-30 | $1.42K 10-Q · filed 2020-01-09 | $2.61K derived: sum of 2 quarters · filed 2020-10-15 | $3.72K derived: sum of 3 quarters · filed 2020-10-15 | $4.83K derived: sum of 4 quarters · filed 2020-10-15 | ||
| 2019-08-31 | $1.19K derived: 10-K 12 month − 10-Q 9 month · filed 2020-10-15 | $2.30K derived: sum of 2 quarters · filed 2020-10-15 | $3.41K derived: sum of 3 quarters · filed 2020-10-15 | $4.39K 10-K · filed 2020-10-15 | ||
| 2019-05-31 | $1.11K derived: 10-Q 9 month − 10-Q 6 month · filed 2019-07-08 | $2.23K derived: sum of 2 quarters · filed 2019-07-08 | $3.21K 10-Q · filed 2019-07-08 | $3.21K derived: sum of 4 quarters · filed 2019-11-14 | ||
| 2019-02-28 | $1.11K derived: 10-Q 6 month − 10-Q 3 month · filed 2019-04-15 | $2.10K 10-Q · filed 2019-04-15 | $2.10K derived: sum of 3 quarters · filed 2019-11-14 | $3.25K derived: sum of 4 quarters · filed 2019-11-14 | ||
| 2018-11-30 | $982.00 10-Q · filed 2019-01-11 | $982.00 derived: sum of 2 quarters · filed 2019-11-14 | $2.14K derived: sum of 3 quarters · filed 2019-11-14 | $982.00 derived: sum of 4 quarters · filed 2019-11-14 | ||
| 2018-08-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2019-11-14 | $1.16K derived: sum of 2 quarters · filed 2019-11-14 | $0.00 derived: sum of 3 quarters · filed 2019-11-14 | $1.69K 10-K · filed 2019-11-14 | ||
| 2018-05-31 | $1.16K derived: 10-Q 9 month − 10-Q 6 month · filed 2019-07-08 | $0.00 derived: sum of 2 quarters · filed 2019-07-08 | $1.69K 10-Q · filed 2019-07-08 | $900.00 10-Q · filed 2018-07-13 | ||
| 2018-02-28 | -$1.16K derived: 10-Q 6 month − 10-Q 3 month · filed 2018-04-12 | $528.00 10-Q · filed 2018-04-12 | ||||
| 2017-11-30 | $1.69K 10-Q · filed 2019-01-11 | $221.00 10-Q · filed 2018-01-12 | ||||
| 2017-08-31 | $869.00 10-K · filed 2018-11-14 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Telomir Pharmaceuticals, Inc. (TELO) | United States | $0.084B | |
| NEONC TECHNOLOGIES HOLDINGS, INC. (NTHI) | United States | $0.086B | |
| ONCOLYTICS BIOTECH INC (ONCY) | $0.086B | ||
| Gain Therapeutics, Inc. (GANX) | United States | $0.080B | -4.40 |
| Rallybio Corp (RLYB) | United States | $0.089B | |
| Lifevantage Corp (LFVN) | United States | $0.078B | 15.40 |
| Adicet Bio, Inc. (ACET) | United States | $0.078B | -0.81 |
| Acrivon Therapeutics, Inc. (ACRV) | United States | $0.091B | -1.03 |
| Valion Bio, Inc. (VBIO) | United States | $0.077B | |
| MAIA Biotechnology, Inc. (MAIA) | United States | $0.077B | -2.30 |